Recent advances in the role of Sphingosine 1-phosphate in cancer

Research output: Contribution to journalReview article

Abstract

Sphingosine 1-phosphate (S1P) is a bioactive lipid that binds to a family of G protein-coupled receptors (S1P 1–5) and intracellular targets, such as HDAC1/2, that are functional in normal and pathophysiologic cell biology. There is a significant role for sphingosine 1-phosphate in cancer underpinning the so-called hallmarks, such as transformation and replicative immortality. In this review, we survey the most recent developments concerning the role of sphingosine 1-phosphate receptors, sphingosine kinase and S1P lyase in cancer and the prognostic indications of these receptors and enzymes in terms of disease-specific survival and recurrence. We also provide evidence for identification of new therapeutic approaches targeting sphingosine 1-phosphate to prevent neovascularisation, to revert aggressive and drug-resistant cancers to more amenable forms sensitive to chemotherapy, and to induce cytotoxicity in cancer cells. Finally, we briefly describe current advances in the development of isoform-specific inhibitors of sphingosine kinases for potential use in the treatment of various cancers, where these enzymes have a predominant role. This review will therefore highlight sphingosine 1-phosphate signalling as a promising translational target for precision medicine in stratified cancer patients.

Original languageEnglish
Number of pages19
JournalFEBS Letters
Early online date23 Sep 2020
DOIs
Publication statusE-pub ahead of print - 23 Sep 2020

Keywords

  • sphingosine 1-phosphate
  • sphingosine kinase
  • sphingosine 1-phosphate receptors
  • sphingosine 1-phosphate lyase
  • sphingosine 1-phosphate phosphatase
  • metastasis
  • cancer stem cells

Fingerprint Dive into the research topics of 'Recent advances in the role of Sphingosine 1-phosphate in cancer'. Together they form a unique fingerprint.

  • Cite this